{"entity":{"edinet_code":"E00939","sec_code":"4523","name_ja":"エーザイ株式会社","name_en":"Eisai Co., Ltd.","industry":"医薬品","industry_en":"Pharmaceutical"},"names_note":"English company names are as filed: each company's own annual report states its English name on the cover page. For a company that files no annual report, EDINET's filer registry is used instead. The as-filed Japanese name is always returned alongside.","filing":{"doc_id":"S100YB05","filer_name":"エーザイ株式会社","filer_name_en":"Eisai Co., Ltd.","period_end":"2026-03-31","filed_date":"2026-06-12","sha256":"acb48edd54572c264dce0b6d65875ef5f17a693a1c09edc090286718d8a011a3","status":"partial"},"basis":{"measurement":"carrying_amount","entity_scope":"parent_only","share_scope":"both","trust_included":"unknown","as_of":"2026-03-31","period_type":"annual","labels":{"measurement":"Balance-sheet carrying amount. Under Japanese GAAP listed equities are carried at market with the valuation difference in other comprehensive income, so carrying amount and acquisition cost diverge enormously on positions bought decades ago.","entity_scope":"The reporting company itself (提出会社) — the holding company, excluding the group holders it names separately.","share_scope":"Listed and unlisted shares together.","trust_included":"The filing does not state whether retirement-benefit-trust shares are included. Never guessed — shares contributed to such a trust leave the holder's balance sheet while the settlor normally keeps the right to instruct the vote.","period_type":"From an annual securities report (有価証券報告書). The policy shareholding table appears only in the annual report."},"not_comparable":"Figures are balance-sheet CARRYING AMOUNT at fiscal year end, from the annual securities report. They are NOT comparable with the acquisition-cost or book-value-reduction figures quoted in press coverage and IR presentations, and NOT comparable with interim (half-year) figures, which this product does not hold. Always state the basis with the number, and use check_claim before setting one of our figures against a published one."},"basis_note":"The basis every yen figure on this response is on. entity_scope is read from the filing's own disclosing entities, not assumed: scale_entities and flows each carry their own entity_scope and share_scope, and a figure quoted for one entity is not the group figure.","holdings":[{"holder_table":"reporting","held_name_raw":"㈱マツキヨココカラ＆カンパニー","held_name_en":"MatsukiyoCocokara&Co.","held_sec_code":"3088","match_status":"matched","shares":4545000,"book_value_yen":11481000000,"prior_shares":8445000,"prior_book_value_yen":19766000000,"purpose_ja":"・一般用医薬品販売事業等における取引関係の強化のため保有しています。・定量的な保有効果を検証しています。・なお、当事業年度に保有株式の一部を売却しています。","reciprocal":"有","pct_outstanding":1.1402745133743664,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":1.2770970153238295,"pct_of_holder_assets":0.792277758877327,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":898992000000,"holder_total_assets_yen":1449113000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"日本光電工業㈱","held_name_en":"NIHON KOHDEN CORPORATION","held_sec_code":"6849","match_status":"matched","shares":1087600,"book_value_yen":1582000000,"prior_shares":null,"prior_book_value_yen":null,"purpose_ja":"・医療用医薬品販売事業等における取引関係の強化のため保有しています。・定量的な保有効果を検証しています。・当事業年度に退職給付信託財産の返還を行ったため、拠出していた本株式を特定投資株式として記載しています。・なお、当事業年度に保有株式の一部を売却しています。","reciprocal":"有","pct_outstanding":0.6759370391620867,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.17597486963176537,"pct_of_holder_assets":0.10917023034090509,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":898992000000,"holder_total_assets_yen":1449113000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"㈱インテージホールディングス","held_name_en":"INTAGE HOLDINGS Inc.","held_sec_code":"4326","match_status":"matched","shares":598500,"book_value_yen":1007000000,"prior_shares":null,"prior_book_value_yen":null,"purpose_ja":"・医療用医薬品販売事業等における取引関係の強化のため保有しています。・定量的な保有効果を検証しています。・当事業年度に退職給付信託財産の返還を行ったため、拠出していた本株式を特定投資株式として記載しています。・なお、当事業年度に保有株式の一部を売却しています。","reciprocal":"有","pct_outstanding":1.5540610718737018,"pct_unavailable":null,"pct_basis_period_end":"2026-06-30","pct_share_classes":1,"pct_of_holder_equity":0.11201434495523875,"pct_of_holder_assets":0.06949078505264945,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":898992000000,"holder_total_assets_yen":1449113000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"Cogstate Ltd.","held_name_en":null,"held_sec_code":null,"match_status":"foreign","shares":3991003,"book_value_yen":950000000,"prior_shares":7864623,"prior_book_value_yen":1027000000,"purpose_ja":"・エコシステム戦略における関係の維持・強化を目的として保有しています。・エーザイは、脳の健康度（ブレインパフォーマンス）のセルフチェックツールについて、日本・米国・一部のアジア諸国を対象としたライセンス契約をCogstate Ltd.と締結しています。・定量的な保有効果の記載は困難ですが、事業戦略上のシナジーを企図して保有しています。・なお、当事業年度に保有株式の一部を売却しています。","reciprocal":"無","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":null,"pct_share_classes":null,"pct_of_holder_equity":0.1056739103351309,"pct_of_holder_assets":0.06555734438929194,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":898992000000,"holder_total_assets_yen":1449113000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"ライフネット生命保険㈱","held_name_en":"LIFENET INSURANCE COMPANY","held_sec_code":"7157","match_status":"matched","shares":349000,"book_value_yen":702000000,"prior_shares":349000,"prior_book_value_yen":608000000,"purpose_ja":"・エコシステム戦略における関係の維持・強化を目的として保有しています。　当社が持つ認知症領域における創薬活動や疾患啓発活動の経験・ネットワークと、ライフネット生命の保険商品・関連サービスで培ってきたノウハウや技術を相互に持ち寄り、サービス開発等を進めています。・定量的な保有効果の記載は困難ですが、事業戦略上のシナジーを企図して保有しています。","reciprocal":"無","pct_outstanding":0.4344017941267085,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.07808745795290725,"pct_of_holder_assets":0.048443427117139934,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":898992000000,"holder_total_assets_yen":1449113000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"㈱ほくやく・竹山ホールディングス","held_name_en":"HOKUYAKU TAKEYAMA Holdings,Inc.","held_sec_code":"3055","match_status":"matched","shares":546005,"book_value_yen":503000000,"prior_shares":546005,"prior_book_value_yen":484000000,"purpose_ja":"・医療用医薬品販売事業等における取引関係の強化のため保有しています。・定量的な保有効果を検証しています。","reciprocal":"有","pct_outstanding":2.6561572664208364,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.05595155463007457,"pct_of_holder_assets":0.03471088866085668,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":898992000000,"holder_total_assets_yen":1449113000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"㈱PRISM BioLab","held_name_en":"PRISM BioLab Co.,LTD","held_sec_code":"206A","match_status":"matched","shares":500000,"book_value_yen":90000000,"prior_shares":500000,"prior_book_value_yen":140000000,"purpose_ja":"・医薬品事業戦略における関係性の維持・強化を目的に保有しています。・定量的な保有効果の記載は困難ですが、事業戦略上のシナジーを企図して保有しています。","reciprocal":"無","pct_outstanding":1.3583265417006247,"pct_unavailable":null,"pct_basis_period_end":"2025-09-30","pct_share_classes":1,"pct_of_holder_equity":0.010011212558065034,"pct_of_holder_assets":0.006210695784248709,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":898992000000,"holder_total_assets_yen":1449113000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"㈱スズケン","held_name_en":"SUZUKEN CO.,LTD.","held_sec_code":"9987","match_status":"matched","shares":100,"book_value_yen":1000000,"prior_shares":100,"prior_book_value_yen":0,"purpose_ja":"・医療用医薬品販売事業等における取引関係の強化のため保有しています。・定量的な保有効果を検証しています。","reciprocal":"有","pct_outstanding":0.0001478460952900019,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.00011123569508961148,"pct_of_holder_assets":6.900773093609678e-05,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":898992000000,"holder_total_assets_yen":1449113000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"㈱バイタルケーエスケー・ホールディングス","held_name_en":"VITAL KSK HOLDINGS,INC.","held_sec_code":"3151","match_status":"matched","shares":null,"book_value_yen":null,"prior_shares":298854,"prior_book_value_yen":376000000,"purpose_ja":"・医療用医薬品販売事業等における取引関係の強化のため保有していましたが、当事業年度に全株式を売却しています。","reciprocal":"有","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":null,"pct_of_holder_assets":null,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":898992000000,"holder_total_assets_yen":1449113000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false}],"holders":[{"holder_name":"東京海上ホールディングス株式会社","holder_name_en":"Tokio Marine Holdings, Inc.","holder_sec_code":"8766","doc_id":"S100YLS8","period_end":"2026-03-31","holder_table":"largest","shares":1728796,"book_value_yen":8420000000,"prior_shares":1728796,"prior_book_value_yen":7165000000,"purpose_ja":"保険事業における顧客企業との長期的かつ安定的な保険取引関係の維持および強化を図り、当社グループの企業価値を高めることを目的として、保有してきたものです。現在は、当社グループのリスクポートフォリオを見直し、社会課題解決や成長分野等に対して資本を振り向けるため、売却方針に則り保有をゼロにすることをめざしています。","reciprocal":"無","pct_outstanding":0.6128006098698792,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.1542810895176627,"pct_of_holder_assets":0.02634383269601282,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":5457571000000,"holder_total_assets_yen":31961940000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"株式会社マツキヨココカラ＆カンパニー","holder_name_en":"MatsukiyoCocokara&Co.","holder_sec_code":"3088","doc_id":"S100YD1I","period_end":"2026-03-31","holder_table":"reporting","shares":819900,"book_value_yen":3993000000,"prior_shares":819900,"prior_book_value_yen":3398000000,"purpose_ja":"（保有目的）商品の安定供給（商品仕入）を通じた当社事業の円滑化のため保有（定量的な保有効果）（注）２","reciprocal":"有","pct_outstanding":0.2906272458013056,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.733399332538649,"pct_of_holder_assets":0.5282927003523274,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":544451000000,"holder_total_assets_yen":755831000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"ＭＳ＆ＡＤインシュアランスグループホールディングス株式会社","holder_name_en":"MS&AD Insurance Group Holdings, Inc.","holder_sec_code":"8725","doc_id":"S100YNCJ","period_end":"2026-03-31","holder_table":"second_largest","shares":600083,"book_value_yen":2923000000,"prior_shares":741883,"prior_book_value_yen":3075000000,"purpose_ja":"保険取引先との関係の維持・強化を目的として安定保有していたが、保有方針については③a.(a)に記載のとおり","reciprocal":"無","pct_outstanding":0.21270943961725197,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.0605785531611518,"pct_of_holder_assets":0.010205715165577516,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":4825140000000,"holder_total_assets_yen":28640815000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"久光製薬株式会社","holder_name_en":"HISAMITSU PHARMACEUTICAL CO.,INC.","holder_sec_code":"4530","doc_id":"S100VT69","period_end":"2025-02-28","holder_table":"reporting","shares":251700,"book_value_yen":1084000000,"prior_shares":251700,"prior_book_value_yen":1574000000,"purpose_ja":"協力関係の構築により、企業価値向上を図るため。","reciprocal":"有","pct_outstanding":0.08921863542000598,"pct_unavailable":null,"pct_basis_period_end":"2025-03-31","pct_share_classes":1,"pct_of_holder_equity":0.38796451055270625,"pct_of_holder_assets":0.31597234367530636,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":279407000000,"holder_total_assets_yen":343068000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"株式会社ほくやく・竹山ホールディングス","holder_name_en":"HOKUYAKU TAKEYAMA Holdings,Inc.","holder_sec_code":"3055","doc_id":"S100YJPG","period_end":"2026-03-31","holder_table":"largest","shares":217400,"book_value_yen":1058000000,"prior_shares":217400,"prior_book_value_yen":901000000,"purpose_ja":"（保有目的）主として医薬品卸売事業における安定的な商品取引関係および医薬品専門情報収集等の強化のため（定量的な保有効果）　（注）","reciprocal":"有","pct_outstanding":0.07706106017466013,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":1.6361752470500905,"pct_of_holder_assets":0.6795773517037608,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":64663000000,"holder_total_assets_yen":155685000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"株式会社バイタルケーエスケー・ホールディングス","holder_name_en":"VITAL KSK HOLDINGS,INC.","holder_sec_code":"3151","doc_id":"S100YDSN","period_end":"2026-03-31","holder_table":"largest","shares":206012,"book_value_yen":1003000000,"prior_shares":206012,"prior_book_value_yen":853000000,"purpose_ja":"①商品の確保や仕入の円滑化のため　②該当なし　③ＡがＢを上回っております　④該当なし","reciprocal":"無","pct_outstanding":0.07302439341629294,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.8449375352759315,"pct_of_holder_assets":0.3128821342117741,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":118707000000,"holder_total_assets_yen":320568000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"日本光電工業株式会社","holder_name_en":"NIHON KOHDEN CORPORATION","holder_sec_code":"6849","doc_id":"S100YHO8","period_end":"2026-03-31","holder_table":"reporting","shares":154408,"book_value_yen":752000000,"prior_shares":231508,"prior_book_value_yen":959000000,"purpose_ja":"同株式は創薬支援関連の研究開発における円滑な業務推進のため保有しています。当社は保有株式について資本コストを踏まえ、配当・取引額等に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有しています。定量的な保有効果については、取引先との営業秘密との判断により記載しませんが、上記方針に基づき検証を行った結果、当事業年度に一部売却を実施しました。","reciprocal":"有","pct_outstanding":0.05473249392570801,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.41818667141204735,"pct_of_holder_assets":0.2931339606607988,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":179824000000,"holder_total_assets_yen":256538000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"大成建設株式会社","holder_name_en":"TAISEI CORPORATION","holder_sec_code":"1801","doc_id":"S100YDJC","period_end":"2026-03-31","holder_table":"reporting","shares":105000,"book_value_yen":511000000,"prior_shares":105000,"prior_book_value_yen":435000000,"purpose_ja":"建設事業における取引関係強化のため保有しております。営業上の取引等の概要及び定量的な保有効果については、上記記載をご参照ください。","reciprocal":"無","pct_outstanding":0.03721900330422868,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.051619759356965285,"pct_of_holder_assets":0.018824482879298596,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":989931000000,"holder_total_assets_yen":2714550000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"不二硝子株式会社","holder_name_en":"FUJI GLASS CO., LTD.","holder_sec_code":"5212","doc_id":"S100R1Z3","period_end":"2023-03-31","holder_table":"reporting","shares":21991,"book_value_yen":165021000,"prior_shares":21752,"prior_book_value_yen":123336000,"purpose_ja":"主要販売先との取引関係の維持、強化のためエーザイ協力会社持株会への拠出金による購入のため","reciprocal":"無","pct_outstanding":0.007665060147996414,"pct_unavailable":null,"pct_basis_period_end":"2023-03-31","pct_share_classes":1,"pct_of_holder_equity":4.68126486998945,"pct_of_holder_assets":3.3776790029050483,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":3525137000,"holder_total_assets_yen":4885633000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"太陽化学株式会社","holder_name_en":"TAIYO KAGAKU CO.,LTD.","holder_sec_code":"2902","doc_id":"S100YD3Q","period_end":"2026-03-31","holder_table":"reporting","shares":24105,"book_value_yen":117419000,"prior_shares":23751,"prior_book_value_yen":98448000,"purpose_ja":"製品及び商品の販売における協力関係の維持・強化を目的として保有しております。（株式数が増加した理由）取引先持株会を通じた株式の取得","reciprocal":"無","pct_outstanding":0.008544419758556498,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.20653814356827496,"pct_of_holder_assets":0.1687078837339617,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":56851000000,"holder_total_assets_yen":69599000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"株式会社インテージホールディングス","holder_name_en":"INTAGE HOLDINGS Inc.","holder_sec_code":"4326","doc_id":"S100Z55A","period_end":"2026-06-30","holder_table":"reporting","shares":17301,"book_value_yen":71264000,"prior_shares":17300,"prior_book_value_yen":71761000,"purpose_ja":"協業関係の構築、維持及び強化を目的として保有しております。また、同目的のため同社持株会に加入しており、株式数が増加しております。","reciprocal":"有","pct_outstanding":0.006132628344442479,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.2083890573170207,"pct_of_holder_assets":0.14856349602027072,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34197573000,"holder_total_assets_yen":47968715000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"株式会社博報堂ＤＹホールディングス","holder_name_en":"HAKUHODO DY HOLDINGS INCORPORATED","holder_sec_code":"2433","doc_id":"S100YHXU","period_end":"2026-03-31","holder_table":"largest","shares":11336,"book_value_yen":55000000,"prior_shares":11336,"prior_book_value_yen":46000000,"purpose_ja":"(保有目的)取引関係の維持強化のため(定量的な保有効果)※１","reciprocal":"無","pct_outstanding":0.004018234490064155,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.01366405310596349,"pct_of_holder_assets":0.005087260390035629,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":402516000000,"holder_total_assets_yen":1081132000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"笹徳印刷株式会社","holder_name_en":"Sasatoku Printing Co., Ltd.","holder_sec_code":"3958","doc_id":"S100Z33V","period_end":"2026-06-30","holder_table":"reporting","shares":13237,"book_value_yen":54526000,"prior_shares":13106,"prior_book_value_yen":54364000,"purpose_ja":"(保有目的)事業上の関係構築を図るため、継続して保有しており、持株会を通じた取得により株式数が増加しております。(定量的な保有効果)(注)２","reciprocal":"無","pct_outstanding":0.0046920756832197616,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.565877462403957,"pct_of_holder_assets":0.3520954184653984,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":9635655000,"holder_total_assets_yen":15486143000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"井村屋グループ株式会社","holder_name_en":"IMURAYA GROUP CO., LTD.","holder_sec_code":"2209","doc_id":"S100YD52","period_end":"2026-03-31","holder_table":"reporting","shares":null,"book_value_yen":6457000,"prior_shares":null,"prior_book_value_yen":4250000,"purpose_ja":"取引関係の円滑化及び維持・強化による将来的な企業価値向上を行うため、継続して保有しております。また、同社の取引先持株会に加入していることから保有株数が増加しています。","reciprocal":"無","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.025795231801138376,"pct_of_holder_assets":0.014903244889025988,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":25031758000,"holder_total_assets_yen":43326135000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"小林製薬株式会社","holder_name_en":"KOBAYASHI PHARMACEUTICAL CO.,LTD.","holder_sec_code":"4967","doc_id":"S100XSXS","period_end":"2025-12-31","holder_table":"reporting","shares":100,"book_value_yen":0,"prior_shares":null,"prior_book_value_yen":null,"purpose_ja":"当事業年度より、保有目的を純投資目的から純投資目的以外の目的に変更しました。株主総会出席のために保有しております。","reciprocal":"無","pct_outstanding":3.544666981355112e-05,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.0,"pct_of_holder_assets":0.0,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":211008000000,"holder_total_assets_yen":275329000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"株式会社電通グループ","holder_name_en":"DENTSU GROUP INC.","holder_sec_code":"4324","doc_id":"S100Y36E","period_end":"2025-12-31","holder_table":"reporting","shares":100,"book_value_yen":0,"prior_shares":100,"prior_book_value_yen":0,"purpose_ja":"（注）１．２．","reciprocal":"無","pct_outstanding":3.544666981355112e-05,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.0,"pct_of_holder_assets":0.0,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":374849000000,"holder_total_assets_yen":3206787000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"株式会社スズケン","holder_name_en":"SUZUKEN CO.,LTD.","holder_sec_code":"9987","doc_id":"S100YFRU","period_end":"2026-03-31","holder_table":"reporting","shares":100,"book_value_yen":0,"prior_shares":100,"prior_book_value_yen":0,"purpose_ja":"保有目的 　商品の安定仕入を目的とし、同社との良好な取引　関係の維持、強化定量的な保有効果　当社の資本コスト、投下資本（株価）、受取配当金及び取引高を総合的に勘案し検証しております","reciprocal":"有","pct_outstanding":3.544666981355112e-05,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.0,"pct_of_holder_assets":0.0,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":416012000000,"holder_total_assets_yen":1155766000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"アサヒグループホールディングス株式会社","holder_name_en":"Asahi Group Holdings, Ltd.","holder_sec_code":"2502","doc_id":"S100YVTZ","period_end":"2025-12-31","holder_table":"reporting","shares":100,"book_value_yen":0,"prior_shares":100,"prior_book_value_yen":0,"purpose_ja":"同社株主総会へ参加し、当社株主総会運営の参考とするため、少数を保有しています。","reciprocal":"無","pct_outstanding":3.544666981355112e-05,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.0,"pct_of_holder_assets":0.0,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":3003052000000,"holder_total_assets_yen":6028414000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"ヤマハ発動機株式会社","holder_name_en":"Yamaha Motor Co., Ltd.","holder_sec_code":"7272","doc_id":"S100YTNF","period_end":"2025-12-31","holder_table":"reporting","shares":100,"book_value_yen":0,"prior_shares":100,"prior_book_value_yen":0,"purpose_ja":"株主に対する情報提供方法等の情報収集のため。","reciprocal":"無","pct_outstanding":3.544666981355112e-05,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.0,"pct_of_holder_assets":0.0,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":1132238000000,"holder_total_assets_yen":2902584000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"東邦ホールディングス株式会社","holder_name_en":"TOHO HOLDINGS CO.,LTD.","holder_sec_code":"8129","doc_id":"S100YHSN","period_end":"2026-03-31","holder_table":"reporting","shares":null,"book_value_yen":null,"prior_shares":9300,"prior_book_value_yen":38000000,"purpose_ja":"同上","reciprocal":"無","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":null,"pct_of_holder_assets":null,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":271560000000,"holder_total_assets_yen":740781000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"アステナホールディングス株式会社","holder_name_en":"Astena Holdings Co., Ltd.","holder_sec_code":"8095","doc_id":"S100XN2T","period_end":"2025-11-30","holder_table":"reporting","shares":null,"book_value_yen":null,"prior_shares":34858,"prior_book_value_yen":162000000,"purpose_ja":"定量的な保有効果の記載は困難ですが、主にファインケミカル事業、ＨＢＣ・食品事業における取引先であり、良好な関係の維持、強化を図るために保有しておりましたが、当事業年度において全株式を売却いたしました。","reciprocal":"無","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":null,"pct_of_holder_assets":null,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":27397000000,"holder_total_assets_yen":75441000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"株式会社バイタルケーエスケー・ホールディングス","holder_name_en":"VITAL KSK HOLDINGS,INC.","holder_sec_code":"3151","doc_id":"S100YDSN","period_end":"2026-03-31","holder_table":"second_largest","shares":null,"book_value_yen":null,"prior_shares":50275,"prior_book_value_yen":208000000,"purpose_ja":"①商品の確保や仕入の円滑化のため　②該当なし　③当事業年度中に売却したため、保有効果は検証しておりません　④該当なし","reciprocal":"無","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":null,"pct_of_holder_assets":null,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":118707000000,"holder_total_assets_yen":320568000000,"implausible":false,"reciprocal_held_both_ways":false}],"reclassified":[],"reclassified_note":"As filed, from the annual report's 保有目的を変更した投資株式 table. direction=to_pure means the filer moved the holding from a policy shareholding to 純投資目的 (pure investment); the shares are not necessarily sold, and the position leaves the named policy table in the year of the change. direction=to_policy is the reverse. fy_of_change_ja is the fiscal year the filer states the change took effect, verbatim — some filers list more than one. A filing repeats these rows for several years after the change, so this is a standing disclosure, not a one-year event.","implausible_note":"A row is flagged implausible when its two filed numbers are mutually impossible — book value ÷ shares of ¥1,000,000 or more, which no listed Japanese share reaches. It is a filer tagging error (a value entered at the wrong scale, or a share count in thousands), not an extraction error: the values match the filing's XBRL exactly. Flagged rows are still returned, exactly as filed, but are excluded from the yen aggregates here and counted in excluded_positions / excluded_yen so the exclusion is visible.","notes":[{"holder_table":"reporting","note_no":"1","text_ja":"(注1) 貸借対照表計上額の上位銘柄を選定する段階で、特定投資株式とみなし保有株式を合算していません。"},{"holder_table":"reporting","note_no":"2","text_ja":"(注2) みなし保有株式は退職給付信託に設定しているものであり、「貸借対照表計上額」欄には当事業年度末日における時価に議決権行使の指図権限の対象となる株式数を乗じて得た額を記載しています。"}],"notes_note":"The filing's own numbered footnotes to the named policy table, verbatim. The XBRL numbers them (注)1, (注)2 … and gives no link back to a row, so a note is tied to a position only where it names that issuer.","flows":[{"holder_table":"reporting","share_class":"listed","issues_increased":2,"acquisition_cost_yen":4036000000,"issues_decreased":5,"sale_proceeds_yen":12419000000,"entity_scope":"parent_only","share_scope":"listed"},{"holder_table":"reporting","share_class":"unlisted","issues_increased":6,"acquisition_cost_yen":1042000000,"issues_decreased":2,"sale_proceeds_yen":249000000,"entity_scope":"parent_only","share_scope":"unlisted"}],"flows_note":"The filer's own tally, as filed, of how many issues increased or decreased during the year and the yen involved — acquisition cost for increases, sale proceeds for decreases. Read against the reclassification table this separates what was actually sold from what merely changed category. Counts are as filed and are not corrected for filer tagging errors.","no_reduction_measure":"This product holds sale proceeds (売却価額), as filed, for one fiscal year. It does NOT hold a book-value-reduction measure. The two are different measures and must never be presented as equivalent.","scale":{"policy_total_yen":29361000000,"listed_yen":16314000000,"unlisted_yen":13047000000,"listed_issues":8,"unlisted_issues":43,"equity_yen":898992000000,"equity_basis":"ifrs_consolidated_excl_nci","total_assets_yen":1449113000000,"assets_basis":"ifrs_consolidated","pct_of_equity":3.2659912435260825,"pct_of_assets":2.026135988014737,"equity_basis_label":"Consolidated equity attributable to owners of the parent (IFRS)","assets_basis_label":"Consolidated total equity (IFRS)","equity_calc":"total policy shareholdings ÷ shareholders' equity × 100, both as filed in this annual securities report","assets_calc":"total policy shareholdings ÷ total assets × 100, both as filed in this annual securities report"},"scale_entities":[{"holder_table":"reporting","share_class":"listed","book_value_yen":16314000000,"issue_count":8,"holder_table_label":"The filer itself","entity_scope":"parent_only","share_scope":"listed"},{"holder_table":"reporting","share_class":"unlisted","book_value_yen":13047000000,"issue_count":43,"holder_table_label":"The filer itself","entity_scope":"parent_only","share_scope":"unlisted"}],"scale_history":[{"year":"2022","period_end":"2022-03-31","policy_total_yen":29988000000,"equity_yen":748821000000,"equity_basis":"ifrs_consolidated_excl_nci","pct_of_equity":4.00469538113915,"pct_of_assets":2.419723799034144},{"year":"2023","period_end":"2023-03-31","policy_total_yen":30835000000,"equity_yen":799959000000,"equity_basis":"ifrs_consolidated_excl_nci","pct_of_equity":3.8545725468430256,"pct_of_assets":2.4407329718605295},{"year":"2024","period_end":"2024-03-31","policy_total_yen":34225000000,"equity_yen":875614000000,"equity_basis":"ifrs_consolidated_excl_nci","pct_of_equity":3.9086857907708192,"pct_of_assets":2.455519052603711},{"year":"2025","period_end":"2025-03-31","policy_total_yen":33688000000,"equity_yen":841417000000,"equity_basis":"ifrs_consolidated_excl_nci","pct_of_equity":4.003722292276006,"pct_of_assets":2.429632749556993},{"year":"2026","period_end":"2026-03-31","policy_total_yen":29361000000,"equity_yen":898992000000,"equity_basis":"ifrs_consolidated_excl_nci","pct_of_equity":3.2659912435260825,"pct_of_assets":2.026135988014737}],"scale_note":"The policy total is Official (as filed) — the filing's own total carrying amount for the whole policy bucket, listed and unlisted, summed across the entities the filing discloses. It is a floor: holdings at group companies the filing does not name are disclosed nowhere and are not included. The percentages are calculated, not filed, and carry their formula. equity_basis names which figure the denominator is, because filers report under Japanese, IFRS or US accounting standards and an adopter of the latter two stops tagging the Japanese consolidated figure — a parent-only denominator is a different measure and is labelled as one, never silently mixed with a group figure. Percentages are null where equity or total assets is missing or not positive; missing is never shown as zero.","scale_reference":"ISS's Japan proxy voting guidelines recommend a vote against the top executive at a company that allocates 20 percent or more of its net assets to cross-shareholdings, a policy effective from February 2022. ISS counts unilateral holdings, not only mutual ones.","ownership_calc":"shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end","ownership_note":"Derived, not filed. The denominator is the issuer's own reported issued shares less treasury shares, from its annual report nearest this holding's fiscal year end on either side — pct_basis_period_end gives that date, and it can fall after the holding's date where that report is the closer one. For a single-class listed stock this equals the stake's share of market capitalisation. It is null where the issuer files no annual report we hold; where the issuer's share count moves by half or more across the window, because a split or issue makes the share base indeterminate; and where the result would exceed 100%, which is a data fault rather than a stake. It is less exact where the issuer has more than one share class (pct_share_classes > 1), because treasury shares are reported across all classes.","holder_share_calc":"this position's book value ÷ the holder's shareholders' equity (or total assets) × 100, both as filed in the holder's own annual securities report","holder_share_note":"The mirror of pct_outstanding. That sizes a stake against the ISSUER — how much of the issuer this holder owns. pct_of_holder_equity and pct_of_holder_assets size the same position against the HOLDER: how much of its own capital is committed to this one name. Calculated, not filed. Null where the holder's filing gives no usable denominator, never zero. holder_equity_basis says which accounting figure the denominator is, and a parent_only basis is not comparable with a consolidated one. A position CAN legitimately exceed 100% of equity — a holder whose book equity is smaller than one long-held stake is a real and commercially interesting case, not an error — so no ceiling is imposed. Extreme values are worth checking against the filing: where the position's own two filed numbers are mutually impossible the row is marked `implausible`, but that test catches only scale errors visible per share, so it does not catch every bad figure. The book value and share count are returned alongside so the reader can check.","action_calc":"keyword match over the filing's own stated purpose and table footnotes: 株式分割、株式併合、株式交換、株式移転、会社分割、合併、持株会社、商号変更、公開買付、上場廃止","ratio_calc":"current shares ÷ prior shares where that ratio is an exact whole number (or its exact reciprocal) — the signature of a split or a consolidation rather than a trade","history":[{"year":"2019","period_end":"2019-03-31","named_holdings":24,"book_value_yen":43197000000},{"year":"2022","period_end":"2022-03-31","named_holdings":10,"book_value_yen":25236000000},{"year":"2023","period_end":"2023-03-31","named_holdings":11,"book_value_yen":25025000000},{"year":"2024","period_end":"2024-03-31","named_holdings":10,"book_value_yen":23571000000},{"year":"2025","period_end":"2025-03-31","named_holdings":8,"book_value_yen":22401000000},{"year":"2026","period_end":"2026-03-31","named_holdings":9,"book_value_yen":16316000000}],"history_note":"One point per annual report filed. Each year's book value is as filed; book values are fair-valued at period end, so a change reflects both trading and market moves.","provenance":{"trust":"official","note":"Figures exactly as filed in each company's 有価証券報告書 (annual securities report), EDINET. Raw filings archived with SHA-256; doc_id links to the source filing."}}